Journal club program highlighting recent advances in renal cell cancer research. Each journal club should take five minutes to complete and is comprised of an abbreviated slide set along with edited commentary.
Sunitinib Continuous 37.5 mg/Day Dosing in Cytokine-Refractory Metastatic RCC and Pazopanib in Patients with Treatment-Naïve or Cytokine-Pretreated Advanced RCC
Recorded discussions from case-based meetings featuring community oncologists presenting actual but de-identified cases to a panel of clinical investigators.
Featuring interviews with Drs Thomas E Hutson, Walter Stadler, Brian I Rini and Nicholas J Vogelzang (Text and Audio Content). Also visit ResearchToPractice.com/RCCUSEvideo09 for related faculty videos.
Edited proceedings from closed roundtable discussions among clinical investigators debating newly published data and controversial issues central to patient care.
Roundtable participants include Drs Michael B Atkins, Robert A Figlin, Thomas E Hutson, Eric Jonasch, Robert J Motzer and David I Quinn. (Text and Audio Content)
